Partial cellular reprogramming reduces acute ischemic brain injury in aged mice
Published in Brain/Neurology, Ischemia, Journals.
Published October 24, 2026.
A study published October 23 in Aging Cell reports that short cycles of partial cellular reprogramming reduced acute ischemic brain injury in aged mice.
Paula R. Mallavibarrena and colleagues used a genetically engineered, inducible mouse model to express the four Yamanaka factors, collectively called OSKM. The animals underwent permanent middle cerebral artery occlusion, an experimental model of interrupted blood supply to the brain.
Forty-eight hours after ischemia, OSKM-induced mice had smaller damaged areas than wild-type controls and performed better on neurological scoring and a tightrope sensorimotor test. Researchers also observed preserved myelin markers and neuronal density, more oligodendrocytes and their precursors, and less astrocyte activation. Microglial responses were comparable between genotypes.
Limits: These are short-term findings in an engineered mouse model. They do not establish a treatment that can be administered after a human stroke, durable recovery, or lifespan extension. Long-term safety and a clinically usable delivery method remain questions for further research.
The work supports investigating whether controlled reprogramming can strengthen the aging brain’s resilience to loss of blood supply.
Source: Mallavibarrena et al., Aging Cell, October 23, 2026.